Ginkgo Bioworks is a publicly listed company tracked for investment-relevant business developments.
Ginkgo is focusing on the 'back end' of biology — making physical experimentation cheaper and faster via autonomous robotic labs — and now sells both the hardware (reconfigurable automation carts) and a cloud lab service, targeting pharma, national labs, and eventually individual scientists.